UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Mechanisms of Disease: oncogene addiction-a rationale for molecular targeting in cancer therapy

Nature clinical practice. Oncology, 2006-08, Vol.3 (8), p.448-457

2006

Volltextzugriff (PDF)

Resveratrol Induces Growth Inhibition, S-phase Arrest, Apoptosis, and Changes in Biomarker Expression in Several Human Cancer Cell Lines

Clinical cancer research, 2002-03, Vol.8 (3), p.893-903

2002

Volltextzugriff (PDF)

Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair-Deficient Cancer: Results From the Phase II KEYNOTE-158 Study

Journal of clinical oncology, 2020-01, Vol.38 (1), p.1-10

2020

Volltextzugriff (PDF)

T-Cell-Inflamed Gene-Expression Profile, Programmed Death Ligand 1 Expression, and Tumor Mutational Burden Predict Efficacy in Patients Treated With Pembrolizumab Across 20 Cancers: KEYNOTE-028

Journal of clinical oncology, 2019-02, Vol.37 (4), p.318-327

2019

Volltextzugriff (PDF)

Comparing Genetic Ancestry and Self-Described Race in African Americans Born in the United States and in Africa

Cancer epidemiology, biomarkers & prevention, 2008-06, Vol.17 (6), p.1329-1338

2008

Volltextzugriff (PDF)

Survival in BRAF V600–Mutant Advanced Melanoma Treated with Vemurafenib

The New England journal of medicine, 2012-02, Vol.366 (8), p.707-714

2012

Volltextzugriff (PDF)

Somatic evolution of head and neck cancer – Biological robustness and latent vulnerability

Molecular oncology, 2013-02, Vol.7 (1), p.14-28

2013

Volltextzugriff (PDF)

p38 MAP kinase controls EGF receptor downregulation via phosphorylation at Ser1046/1047

Cancer letters, 2009-05, Vol.277 (1), p.108-113

2009

Volltextzugriff (PDF)

Pharmacodynamic Effects and Mechanisms of Resistance to Vemurafenib in Patients With Metastatic Melanoma

Journal of clinical oncology, 2013-05, Vol.31 (14), p.1767-1774

2013

Volltextzugriff (PDF)

Analysis of Dermatologic Events in Vemurafenib‐Treated Patients With Melanoma

The oncologist (Dayton, Ohio), 2013-03, Vol.18 (3), p.314-322

2013

Volltextzugriff (PDF)

The effects of a high-fat meal on single-dose vemurafenib pharmacokinetics

Journal of clinical pharmacology, 2014-04, Vol.54 (4), p.368-374

2014

Volltextzugriff (PDF)

(−)-Epigallocatechin gallate causes internalization of the epidermal growth factor receptor in human colon cancer cells

Carcinogenesis (New York), 2008-10, Vol.29 (10), p.1986-1993

2008

Volltextzugriff (PDF)

A case of laryngeal carcinoma in a young adult with dyskeratosis congenita

International journal of clinical oncology, 2010-08, Vol.15 (4), p.428-432

2010

Volltextzugriff (PDF)

Fear, Knowledge, and Efficacy Beliefs Differentially Predict the Frequency of Digital Rectal Examination Versus Prostate Specific Antigen Screening in Ethnically Diverse Samples of Older Men

American journal of men's health, 2007-03, Vol.1 (1), p.29-43

2007

Volltextzugriff (PDF)

Sulindac Sulfide and Exisulind Inhibit Expression of the Estrogen and Progesterone Receptors in Human Breast Cancer Cells

Clinical cancer research, 2006-06, Vol.12 (11), p.3478-3484

2006

Volltextzugriff (PDF)

Phase Ib Randomized, Double-Blinded, Placebo-Controlled, Dose Escalation Study of Polyphenon E in Patients with Barrett's Esophagus

Cancer prevention research (Philadelphia, Pa.), 2015-12, Vol.8 (12), p.1131-1137

2015

Volltextzugriff (PDF)

A case of primary Hodgkin's lymphoma of the parotid gland

Auris, nasus, larynx, 2008-09, Vol.35 (3), p.440-442

2008

Volltextzugriff (PDF)

Pembrolizumab therapy for microsatellite instability high (MSI-H) colorectal cancer (CRC) and non-CRC

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.3071-3071

2017

Volltextzugriff (PDF)

Cyclin D1 Overexpression is Associated with Estrogen Receptor Expression in Caucasian but not African-American Breast Cancer

Anticancer research, 2005-01, Vol.25 (1A), p.273-281

2005

Volltextzugriff (PDF)

EGCG inhibits activation of HER3 and expression of cyclooxygenase-2 in human colon cancer cells

Journal of experimental therapeutics & oncology, 2005, Vol.5 (1), p.69-78

2005

Volltextzugriff (PDF)

A single‐dose mass balance and metabolite‐profiling study of vemurafenib in patients with metastatic melanoma

Pharmacology research & perspectives, 2015-03, Vol.3 (2), p.e00113-n/a

2015

Volltextzugriff (PDF)

17HSD 2 may be Higher in African-American Breast Cancer and is Associated with Estrogen Receptor-negative Tumors

Cancer genomics & proteomics, 2007-09, Vol.4 (5), p.341-348

2007

Volltextzugriff (PDF)

African‐American/White differences in breast carcinoma

Cancer, 2005-08, Vol.104 (3), p.661-662

2005

Volltextzugriff (PDF)

Efficacy and safety of MCLA-129, an anti-EGFR/c-MET bispecific antibody, in non-small-cell lung cancer (NSCLC) with c-METexon 14 skipping mutations ( MET ex14)

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.8583-8583

2024

Volltextzugriff (PDF)

RAS Mutations in Cutaneous Squamous-Cell Carcinomas in Patients Treated with BRAF Inhibitors

The New England journal of medicine, 2012-01, Vol.366 (3), p.207-215

2012

Volltextzugriff (PDF)

1 – 25 von 504

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(460)
Mit Volltextzugriff
(398)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(500)
Deutsch
(1)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(363)
Life Sciences & Biomedicine
(283)
Humans
(223)
Male
(124)
Female
(123)
Middle Aged
(74)
Biological And Medical Sciences
(68)
Adult
(64)
Aged
(62)
Animals
(60)
Oncology
(58)
Physical Sciences
(58)
Medical Sciences
(57)
Science & Technology - Other Topics
(36)
General & Internal Medicine
(31)
Multidisciplinary Sciences
(29)
Patients
(28)
Tumors
(28)
Aged, 80 And Over
(27)
Life Sciences
(27)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(4)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Mechanisms of Disease: oncogene addiction-a rationale for molecular targeting in cancer therapy

Resveratrol Induces Growth Inhibition, S-phase Arrest, Apoptosis, and Changes in Biomarker Expression in Several Human Cancer Cell Lines

Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair-Deficient Cancer: Results From the Phase II KEYNOTE-158 Study

T-Cell-Inflamed Gene-Expression Profile, Programmed Death Ligand 1 Expression, and Tumor Mutational Burden Predict Efficacy in Patients Treated With Pembrolizumab Across 20 Cancers: KEYNOTE-028

Comparing Genetic Ancestry and Self-Described Race in African Americans Born in the United States and in Africa

Survival in BRAF V600–Mutant Advanced Melanoma Treated with Vemurafenib

Somatic evolution of head and neck cancer – Biological robustness and latent vulnerability

p38 MAP kinase controls EGF receptor downregulation via phosphorylation at Ser1046/1047

Pharmacodynamic Effects and Mechanisms of Resistance to Vemurafenib in Patients With Metastatic Melanoma

Analysis of Dermatologic Events in Vemurafenib‐Treated Patients With Melanoma

The effects of a high-fat meal on single-dose vemurafenib pharmacokinetics

(−)-Epigallocatechin gallate causes internalization of the epidermal growth factor receptor in human colon cancer cells

A case of laryngeal carcinoma in a young adult with dyskeratosis congenita

Fear, Knowledge, and Efficacy Beliefs Differentially Predict the Frequency of Digital Rectal Examination Versus Prostate Specific Antigen Screening in Ethnically Diverse Samples of Older Men

Sulindac Sulfide and Exisulind Inhibit Expression of the Estrogen and Progesterone Receptors in Human Breast Cancer Cells

Phase Ib Randomized, Double-Blinded, Placebo-Controlled, Dose Escalation Study of Polyphenon E in Patients with Barrett's Esophagus

A case of primary Hodgkin's lymphoma of the parotid gland

Pembrolizumab therapy for microsatellite instability high (MSI-H) colorectal cancer (CRC) and non-CRC

Cyclin D1 Overexpression is Associated with Estrogen Receptor Expression in Caucasian but not African-American Breast Cancer

EGCG inhibits activation of HER3 and expression of cyclooxygenase-2 in human colon cancer cells

A single‐dose mass balance and metabolite‐profiling study of vemurafenib in patients with metastatic melanoma

17HSD 2 may be Higher in African-American Breast Cancer and is Associated with Estrogen Receptor-negative Tumors

African‐American/White differences in breast carcinoma

Efficacy and safety of MCLA-129, an anti-EGFR/c-MET bispecific antibody, in non-small-cell lung cancer (NSCLC) with c-METexon 14 skipping mutations ( MET ex14)

RAS Mutations in Cutaneous Squamous-Cell Carcinomas in Patients Treated with BRAF Inhibitors

Suchergebnisse filtern